Spectral Medical Inc. (OTCMKTS:EDTXF - Get Free Report) fell 0% on Friday . The company traded as low as $0.62 and last traded at $0.62. 1,800 shares traded hands during trading, a decline of 89% from the average session volume of 15,957 shares. The stock had previously closed at $0.62.
Spectral Medical Stock Down 2.9%
The business's 50 day moving average is $0.57 and its two-hundred day moving average is $0.46. The firm has a market capitalization of $170.59 million, a P/E ratio of -8.55 and a beta of 0.20.
Spectral Medical (OTCMKTS:EDTXF - Get Free Report) last issued its quarterly earnings data on Friday, May 9th. The company reported ($0.03) earnings per share for the quarter. The company had revenue of $0.40 million for the quarter.
Spectral Medical Company Profile
(
Get Free Report)
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
See Also
Before you consider Spectral Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.
While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
